Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluate the Persistence and Immune Memory Induced by a Primary Vaccination Course With GSK Biologicals' MenC-TT (1 Formulation) & GSK Biologicals' Hib-MenC-TT (2 Formulations) or Meningitec™ in Healthy Toddlers Aged 12-15 Months Primed in Study 711202/001

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00135564
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:25.895623+00:00
Published At
2016-09-16T00:00:00+00:00
Record Updated At
2016-09-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-09-16"
protocolSection.identificationModule.nctId
"NCT00135564"
protocolSection.identificationModule.officialTitle
"Evaluate the Persistence and Immune Memory Induced by a Primary Vaccination Course With GSK Biologicals\u0027 MenC-TT (1 Formulation) \u0026 GSK Biologicals\u0027 Hib-MenC-TT (2 Formulations) or Meningitec\u2122 in Healthy Toddlers Aged 12-15 Months Primed in Study 711202/001"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Infections, Meningococcal (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.